In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 501-509

  Sin, Jeong I M ^a   Kim, Jong J ^a   Boyer, Jean D ^a   Ciccarelli, Richard B ^b   Higgins, Terry J ^b   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WLVP Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 4; VIRUS PROTEIN;

ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 2; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION;

EID: 0032889014     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.501-509.1999     Document Type: Article

References (14)

1. Bloom, E. T., and J. A. Horvath. 1994. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity: implications for the age-related decline in CTL. J. Immunol. 152:4242-4254.
2. Bourne, N., L. R. Stanberry, D. I. Bernstein, and D. Lew. 1996. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:800-807.
3. Burton, J. D., R. N. Bramford, C. Peters, A. J. Grant, G. Kurys, C. K. Goldman, J. Brennan, E. Roessler, and T. A. Waldmann. 1994. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4935-4939.
4. Cappel, R., S. Sprecher, F. Rickaert, and F. de Cuer. 1982. Immune response to a DNA free herpes simplex vaccine in man. Arch. Virol. 73:61-67.
5. Carr, J. A., J. Rogerson, M. J. Mulqueen, N. A. Roberts, and R. F. G. Booth. 1997. Interleukin-12 exhibits potent antiviral activity in experimental herpes-virus infections. J. Virol. 71:7799-7803.
6. Chow, Y.-H., W.-L. Huang, W.-K. Chi, Y.-D. Chu, and M.-H. Tao. 1997. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:169-178.
7. Coffman, R. L., B. W. P. Seymour, D. A. Lebman, D. D. Hiraki, J. A. Christiansen, B. Shrader, H. M. Cherwinski, H. F. J. Savelkoul, F. D. Finkelman, M. W. Bond, and T. R. Mosmann. 1988. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102:5-28.
8. Uaheshia, M., N. Kuklin, S. Kanangat, E. Manickan, and B. T. Rouse. 1997. Suppression of ongoing ocular inflammatory disease by tropical administration of plasmid DNA encoding IL-10. J. Immunol. 159:1945-1952.
9. dc Waal-Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
10. Farrar, W. L., H. M. Johnson, and J. J. Farrar. 1981. Regulation of the production of immune Interferon and cytotoxic T lymphocytes by interleukin-2. J. Immunol. 126:1120-1125.
11. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333.
12. Florentine, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.
13. Gately, M. K., A. G. Wolitzky, P. M. Quinn, and R. Chizzonite. 1992. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143:127-142.
14. Germann, T., M. K. Gately, D. S. Schoenhaut, M. Lohoff, F. Mattner, S. Fischer, S.-C. Jin, E. Schmitt, and E. Rude. 1993. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol. 23:1762-1770.